Cytomegalovirus myocarditis in solid organ transplant recipients: A case series and review of literature

被引:8
作者
Scherger, Sias [1 ]
Mathur, Swati [1 ]
Bajrovic, Valida [1 ]
Johnson, Steven C. [1 ]
Benamu, Esther [1 ]
Ramanan, Poornima [1 ]
Wolfel, Gene [2 ]
Levi, Marilyn E. [1 ]
Abidi, Maheen Z. [1 ]
机构
[1] Univ Colorado Denver, Div Infect Dis, Aurora, CO USA
[2] Univ Colorado Denver, Div Cardiol, Aurora, CO USA
关键词
cytomegalovirus; solid organ transplant recipients; ANTI-THYRNOCYTE GLOBULIN; ALLOGRAFT-REJECTION; CALCINEURIN INHIBITOR; RISK-FACTORS; INFECTION; DISEASE; PROPHYLAXIS; BASILIXIMAB; DYSFUNCTION; THERAPY;
D O I
10.1111/tid.13282
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cytomegalovirus (CMV) is a DNA virus of the Herpesviridae family and is estimated to affect 15%-30% of high-risk solid organ transplant recipients. Typical manifestations of CMV end-organ disease in this population include colitis, esophagitis, and pneumonitis, and myocarditis is a rarely reported manifestation. We describe two cases of CMV myocarditis in solid organ transplant recipients and review the literature regarding previously published cases of CMV myocarditis.
引用
收藏
页数:5
相关论文
共 31 条
[1]  
ANDO H, 1992, JPN HEART J, V33, P409
[2]   OBLITERATIVE BRONCHIOLITIS AFTER LUNG AND HEART-LUNG TRANSPLANTATION - AN ANALYSIS OF RISK-FACTORS AND MANAGEMENT [J].
BANDO, K ;
PARADIS, IL ;
SIMILO, S ;
KONISHI, H ;
KOMATSU, K ;
ZULLO, TG ;
YOUSEM, SA ;
CLOSE, JM ;
ZEEVI, A ;
DUQUESNOY, RJ ;
MANZETTI, J ;
KEENAN, RJ ;
ARMITAGE, JM ;
HARDESTY, RL ;
GRIFFITH, BP .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 110 (01) :4-14
[3]   Cytomegalovirus Seroprevalence in the United States: The National Health and Nutrition Examination Surveys, 1988-2004 [J].
Bate, Sheri Lewis ;
Dollard, Sheila C. ;
Cannon, Michael J. .
CLINICAL INFECTIOUS DISEASES, 2010, 50 (11) :1439-1447
[4]   Cyclosporine Versus Tacrolimus: Which Calcineurin Inhibitor Has Influence on Cytomegalovirus Infection in Cardiac Transplantation? [J].
Bond, Marina M. K. ;
Bond, Marisa M. K. ;
Sehn, A. ;
Dias, V. H. ;
Said, T. L. ;
dos Santos, C. C. ;
Finger, M. A. ;
Santos, A. M. G. ;
Neto, J. M. R. .
TRANSPLANTATION PROCEEDINGS, 2018, 50 (03) :809-814
[5]   Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipients [J].
Brennan, DC ;
Garlock, KA ;
Singer, GG ;
Schnitzler, MA ;
Lippmann, BJ ;
Buller, RS ;
Gaudreault-Keener, M ;
Lowell, JA ;
Shenoy, S ;
Howard, TK ;
Storch, GA .
TRANSPLANTATION, 1997, 64 (12) :1843-1846
[6]   Basiliximab and rabbit anti-thyrnocyte globulin for prophylaxis of acute rejection after heart transplantation: A non-inferiority trial [J].
Carrier, Michel ;
Leblanc, Marie-Helene ;
Perrault, Louis P. ;
White, Michel ;
Doyle, Daniel ;
Beaudoin, Danielle ;
Guertin, Marie-Claude .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (03) :258-263
[7]   Risk factors associated with cytomegalovirus infection in heart transplant patients: a prospective, epidemiological study [J].
Delgado, J. F. ;
Manito, N. ;
Almenar, L. ;
Crespo-Leiro, M. ;
Roig, E. ;
Segovia, J. ;
Vazquez de Prada, J. A. ;
Lage, E. ;
Palomo, J. ;
Camprecios, M. ;
Arizon, J. M. ;
Rodriguez-Lambert, J. L. ;
Blasco, T. ;
de la Fuente, L. ;
Pascual, D. ;
Rabago, G. .
TRANSPLANT INFECTIOUS DISEASE, 2011, 13 (02) :136-144
[8]   Immunohistochemically proven cytomegalovirus end-organ disease in solid organ transplant patients:: clinical features and usefulness of conventional diagnostic tests [J].
Fica, A. ;
Cervera, C. ;
Perez, N. ;
Marcos, M. A. ;
Ramirez, J. ;
Linares, L. ;
Soto, G. ;
Navasa, M. ;
Cofan, F. ;
Ricart, M. J. ;
Perez-Villa, F. ;
Pumarola, T. ;
Moreno, A. .
TRANSPLANT INFECTIOUS DISEASE, 2007, 9 (03) :203-210
[9]  
GONWA TA, 1989, TRANSPLANTATION, V47, P197
[10]   CYTOMEGALO-VIRUS INFECTION IS ASSOCIATED WITH CARDIAC ALLOGRAFT-REJECTION AND ATHEROSCLEROSIS [J].
GRATTAN, MT ;
MORENOCABRAL, CE ;
STARNES, VA ;
OYER, PE ;
STINSON, EB ;
SHUMWAY, NE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (24) :3561-3566